Pancreatic Cancer Research

ResearcherJinan UniversityNo recent work listed

Shuying Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0786-5931; OpenAlex author ID A5100607412. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper

Papers 2

  1. Irreversible electroporation combined with chemotherapy and PD-1/PD-L1 blockade enhanced antitumor immunity for locally advanced pancreatic cancer. Co-author DOI 10.3389/fimmu.2023.1193040↗
  2. Value of multi-detector computed tomography combined with serum tumor markers in diagnosis, preoperative, and prognostic evaluation of pancreatic cancer. Last author DOI 10.1186/s12957-022-02785-x↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jianli Su · 1 shared paper, 2022 · strength 0.20
  2. Yunfeng Wang · 1 shared paper, 2022 · strength 0.20
  3. Hongmei Li · 1 shared paper, 2023 · strength 0.18
  4. Yangyang Ma · 1 shared paper, 2023 · strength 0.18
  5. Lizhi Niu · 1 shared paper, 2023 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.